Skip to content

Comparison of anesthetic efficacy of articaine in different anesthetic administration methods and volumes in maxillary first molars

Comparative evaluation of anesthetic efficacy of 1.8 and 3.6 milliliter buccal infiltrations, and buccal plus palatal infiltrations with articaine in maxillary first molars with irreversible pulpitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015011020238N2
Enrollment
45
Registered
2015-03-04
Start date
2014-01-15
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irreversible Pulpitis. Pulpitis

Interventions

Intervention 1: group 1: Maxillary first molar buccal infiltration with 4% Articaine with 1:100000 Epinephrine 1.8 ml. Intervention 2: group 2 :Maxillary first molar buccal infiltration with 4% Artic
Treatment - Other
group 1: Maxillary first molar buccal infiltration with 4% Articaine with 1:100000 Epinephrine 1.8 ml
group 2 :Maxillary first molar buccal infiltration with 4% Articane with 1:100000 Epinephrine 3.6 ml
group 3:Maxillary first molar buccal infiltration with 4% Articaine with 1:100000 Epinephrine 1.8 ml plus palatal infiltration with 4% Articaine with 1:100000 Epinephrine 0.5 ml

Sponsors

Tehran University of Medical Sciences International Campus Dentistry School
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Exclusion criteria: Patients with systemic diseases , Patients that have used any form of sedatives in the past 12 hours , Patients that have allergies to anesthetics or sulfites, pregnancy , Patients that are unable give informed consent , Patients with periapical lesions. Inclusion criteria :Patients between the ages of 18 to 60 , Patients with first maxillary molars diagnosed with Symptomatic Irreversible Pulpitis

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: after 20 minutes. Method of measurement: Visual Analogue Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFardad Kamalian

Tehran University of Medical Sciences International Campus Dentistry School

fardad.kamalian@gmail.com+98 21 5585 1149

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 11, 2026